SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001389
Filing Date
2021-08-12
Accepted
2021-08-12 17:07:05
Documents
68
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lyel-20210630.htm   iXBRL 10-Q 2803338
2 EX-31.1 lyel-20210630ex31_1.htm EX-31.1 15424
3 EX-31.2 lyel-20210630ex31_2.htm EX-31.2 15432
4 EX-32.1 lyel-20210630ex32_1.htm EX-32.1 9164
5 EX-32.2 lyel-20210630ex32_2.htm EX-32.2 9680
6 GRAPHIC img213711897_0.jpg GRAPHIC 54053
  Complete submission text file 0000950170-21-001389.txt   9201440

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lyel-20210630_cal.xml EX-101.CAL 41886
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyel-20210630.xsd EX-101.SCH 55163
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyel-20210630_lab.xml EX-101.LAB 465556
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lyel-20210630_def.xml EX-101.DEF 210210
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyel-20210630_pre.xml EX-101.PRE 369038
12 EXTRACTED XBRL INSTANCE DOCUMENT lyel-20210630_htm.xml XML 1615907
Mailing Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40502 | Film No.: 211168586
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences